Warner-Lambert v Actavis: lessons from ‘the case of the year’

On September 10, 2015 Mr Justice Arnold gave his judgment in the Lyrica (pregabalin) case at the English High Court. UK legal commentators have described this dispute between Warner-Lambert (Pfizer) and Actavis and Mylan as ‘the case of the year’. The litigation has already spawned five previous judgments, mainly interim skirmishes between Warner-Lambert and Actavis, but also a related application against NHS England.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Pharma

Boehringer accuses Dr Reddy’s of ‘weaponising’ plausibility

20 October 2026 In closing arguments last week, the drugmaker urged the UK Patents Court to reject an overly critical approach to plausibility and consider what its patents disclose when read as a whole rather than individually.

Pharma

Boehringer and Dr Reddy’s spar over plausibility as trial wraps up

15 October 2026 A dispute over missing experimental data and patent disclosures draws to a close as Boehringer and Dr Reddy’s deliver their final arguments. The court’s decision could bring greater clarity to the UK approach to plausibility and determine whether Dr Reddy’s can move ahead with its proposed generic launch.

Pharma

Accord’s generic hopes dashed in cyanide antidote ruling

14 October 2026 Efforts to bring a generic cyanide poisoning treatment to market have suffered a setback after a US judge rejected challenges to three patents and criticised the drugmaker’s interpretation of the treatment’s chemical composition.

More features

Boehringer accuses Dr Reddy’s of ‘weaponising’ plausibility

Boehringer and Dr Reddy’s spar over plausibility as trial wraps up

Haynes Boone expands in California with new office

Accord’s generic hopes dashed in cyanide antidote ruling

Novo’s semaglutide protection weakens after European ruling

UK to clamp down on non-compete clauses and long notice periods

Brazilian firm appoints patent strategist to lead department

Novartis pursues Apotex over copies of $2bn skin cancer drug franchise

Warner-Lambert v Actavis: lessons from ‘the case of the year’

More on this story

Editor's picks

Editor's picks

More features